These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 7798624)

  • 1. Occlusion lowers cytokine mRNA levels in essential fatty acid-deficient and normal mouse epidermis, but not after acute barrier disruption.
    Wood LC; Elias PM; Sequeira-Martin SM; Grunfeld C; Feingold KR
    J Invest Dermatol; 1994 Dec; 103(6):834-8. PubMed ID: 7798624
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Barrier disruption increases gene expression of cytokines and the 55 kD TNF receptor in murine skin.
    Wood LC; Stalder AK; Liou A; Campbell IL; Grunfeld C; Elias PM; Feingold KR
    Exp Dermatol; 1997 Apr; 6(2):98-104. PubMed ID: 9209892
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cutaneous barrier perturbation stimulates cytokine production in the epidermis of mice.
    Wood LC; Jackson SM; Elias PM; Grunfeld C; Feingold KR
    J Clin Invest; 1992 Aug; 90(2):482-7. PubMed ID: 1644919
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Barrier function coordinately regulates epidermal IL-1 and IL-1 receptor antagonist mRNA levels.
    Wood LC; Feingold KR; Sequeira-Martin SM; Elias PM; Grunfeld C
    Exp Dermatol; 1994 Apr; 3(2):56-60. PubMed ID: 7921651
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Barrier disruption stimulates interleukin-1 alpha expression and release from a pre-formed pool in murine epidermis.
    Wood LC; Elias PM; Calhoun C; Tsai JC; Grunfeld C; Feingold KR
    J Invest Dermatol; 1996 Mar; 106(3):397-403. PubMed ID: 8648167
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Permeability barrier disruption alters the localization and expression of TNF alpha/protein in the epidermis.
    Tsai JC; Feingold KR; Crumrine D; Wood LC; Grunfeld C; Elias PM
    Arch Dermatol Res; 1994; 286(5):242-8. PubMed ID: 8060154
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cutaneous barrier repair and pathophysiology following barrier disruption in IL-1 and TNF type I receptor deficient mice.
    Man MQ; Wood L; Elias PM; Feingold KR
    Exp Dermatol; 1999 Aug; 8(4):261-6. PubMed ID: 10439223
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanical and metabolic injury to the skin barrier leads to increased expression of murine β-defensin-1, -3, and -14.
    Ahrens K; Schunck M; Podda GF; Meingassner J; Stuetz A; Schröder JM; Harder J; Proksch E
    J Invest Dermatol; 2011 Feb; 131(2):443-52. PubMed ID: 20944649
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alterations in cytokine regulation in aged epidermis: implications for permeability barrier homeostasis and inflammation. I. IL-1 gene family.
    Ye J; Garg A; Calhoun C; Feingold KR; Elias PM; Ghadially R
    Exp Dermatol; 2002 Jun; 11(3):209-16. PubMed ID: 12102659
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential regulation of IL-1 and IL-1 receptor antagonist in HaCaT keratinocytes by tumor necrosis factor-alpha and transforming growth factor-beta 1.
    Kang K; Hammerberg C; Cooper KD
    Exp Dermatol; 1996 Aug; 5(4):218-26. PubMed ID: 8889469
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor necrosis factor-alpha induces interleukin-1 alpha and interleukin-1 receptor antagonist production by cultured human keratinocytes.
    Kutsch CL; Norris DA; Arend WP
    J Invest Dermatol; 1993 Jul; 101(1):79-85. PubMed ID: 8331299
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amphiregulin and nerve growth factor expression are regulated by barrier status in murine epidermis.
    Liou A; Elias PM; Grunfeld C; Feingold KR; Wood LC
    J Invest Dermatol; 1997 Jan; 108(1):73-7. PubMed ID: 8980291
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cutaneous permeability barrier disruption increases fatty acid synthetic enzyme activity in the epidermis of hairless mice.
    Ottey KA; Wood LC; Grunfeld C; Elias PM; Feingold KR
    J Invest Dermatol; 1995 Mar; 104(3):401-4. PubMed ID: 7861009
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Integrity of the permeability barrier is crucial for maintenance of the epidermal calcium gradient.
    Menon GK; Elias PM; Feingold KR
    Br J Dermatol; 1994 Feb; 130(2):139-47. PubMed ID: 8123567
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The changes of epidermal calcium gradient and transitional cells after prolonged occlusion following tape stripping in the murine epidermis.
    Ahn SK; Hwang SM; Jiang SJ; Choi EH; Lee SH
    J Invest Dermatol; 1999 Aug; 113(2):189-95. PubMed ID: 10469302
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Perturbation of epidermal barrier function correlates with initiation of cytokine cascade in human skin.
    Nickoloff BJ; Naidu Y
    J Am Acad Dermatol; 1994 Apr; 30(4):535-46. PubMed ID: 7512582
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The interleukin-6 cytokine system regulates epidermal permeability barrier homeostasis.
    Wang XP; Schunck M; Kallen KJ; Neumann C; Trautwein C; Rose-John S; Proksch E
    J Invest Dermatol; 2004 Jul; 123(1):124-31. PubMed ID: 15191552
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression and regulation of mRNA for putative fatty acid transport related proteins and fatty acyl CoA synthase in murine epidermis and cultured human keratinocytes.
    Harris IR; Farrell AM; Memon RA; Grunfeld C; Elias PM; Feingold KR
    J Invest Dermatol; 1998 Nov; 111(5):722-6. PubMed ID: 9804328
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhanced epidermal Langerhans cell migration in IL-10 knockout mice.
    Wang B; Zhuang L; Fujisawa H; Shinder GA; Feliciani C; Shivji GM; Suzuki H; Amerio P; Toto P; Sauder DN
    J Immunol; 1999 Jan; 162(1):277-83. PubMed ID: 9886396
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Permeability barrier disruption coordinately regulates mRNA levels for key enzymes of cholesterol, fatty acid, and ceramide synthesis in the epidermis.
    Harris IR; Farrell AM; Grunfeld C; Holleran WM; Elias PM; Feingold KR
    J Invest Dermatol; 1997 Dec; 109(6):783-7. PubMed ID: 9406821
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.